RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kabirullah Lutfy to Dose-Response Relationship, Drug

This is a "connection" page, showing publications Kabirullah Lutfy has written about Dose-Response Relationship, Drug.
  1. Singh PK, Lutfy K. Nicotine pretreatment reduced cocaine-induced CPP and its reinstatement in a sex- and dose-related manner in adult C57BL/6J mice. Pharmacol Biochem Behav. 2017 08; 159:84-89.
    View in: PubMed
    Score: 0.120
  2. Lutfy K, Parikh D, Lee DL, Liu Y, Ferrini MG, Hamid A, Friedman TC. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence. Neuroscience. 2016 08 04; 329:318-25.
    View in: PubMed
    Score: 0.110
  3. Tseng A, Nguyen K, Hamid A, Garg M, Marquez P, Lutfy K. The role of endogenous beta-endorphin and enkephalins in ethanol reward. Neuropharmacology. 2013 Oct; 73:290-300.
    View in: PubMed
    Score: 0.090
  4. Marquez P, Hamid A, Lutfy K. The role of NOP receptors in psychomotor stimulation and locomotor sensitization induced by cocaine and amphetamine in mice. Eur J Pharmacol. 2013 May 05; 707(1-3):41-5.
    View in: PubMed
    Score: 0.089
  5. Marquez P, Bebawy D, Leli?vre V, Co?t? AC, Evans CJ, Waschek JA, Lutfy K. The role of endogenous PACAP in motor stimulation and conditioned place preference induced by morphine in mice. Psychopharmacology (Berl). 2009 Jun; 204(3):457-63.
    View in: PubMed
    Score: 0.067
  6. Marquez P, Borse J, Nguyen AT, Hamid A, Lutfy K. The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine. Neuroscience. 2008 Aug 26; 155(3):597-602.
    View in: PubMed
    Score: 0.064
  7. Marquez P, Baliram R, Dabaja I, Gajawada N, Lutfy K. The role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice. Psychopharmacology (Berl). 2008 Apr; 197(3):443-8.
    View in: PubMed
    Score: 0.062
  8. Marquez P, Nguyen AT, Hamid A, Lutfy K. The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine. Neuropharmacology. 2008 Mar; 54(3):564-8.
    View in: PubMed
    Score: 0.061
  9. Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W, Kieffer BL, Takeshima H, Carroll FI, Maidment NT, Evans CJ. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci. 2003 Nov 12; 23(32):10331-7.
    View in: PubMed
    Score: 0.046
  10. Lutfy K, Khaliq I, Carroll FI, Maidment NT. Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats. Psychopharmacology (Berl). 2002 Nov; 164(2):168-76.
    View in: PubMed
    Score: 0.043
  11. Lutfy K, Maidment NT. Sensitization does not develop to cocaine-induced potentiation of the antinociceptive effect of morphine. Brain Res Bull. 2002 May; 58(1):7-12.
    View in: PubMed
    Score: 0.042
  12. Lutfy K, Maidment NT. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test. Br J Pharmacol. 2000 Dec; 131(8):1684-8.
    View in: PubMed
    Score: 0.038
  13. Lutfy K, Doan P, Nguyen M, Weber E. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance. Eur J Pharmacol. 1999 Nov 12; 384(1):1-5.
    View in: PubMed
    Score: 0.035
  14. Lutfy K, Weber E. Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice. Pharmacol Res. 1998 Apr; 37(4):295-302.
    View in: PubMed
    Score: 0.031
  15. Lutfy K, Shen KZ, Woodward RM, Weber E. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test. Brain Res. 1996 Aug 26; 731(1-2):171-81.
    View in: PubMed
    Score: 0.028
  16. Lutfy K, Sadowski B, Marek P, Kwon IS, Keana JF, Weber E. Differential sensitivity of mice bred for stress-induced analgesia to morphine and ACEA-1011 in the formalin test. Pharmacol Biochem Behav. 1996 Jun; 54(2):495-500.
    View in: PubMed
    Score: 0.028
  17. Lutfy K, Keana JF, Weber E. ACEA-1011, a novel NMDA receptor/glycine site antagonist, produces antinociception but not tolerance in the formalin test in mice. NIDA Res Monogr. 1995; 147:220-33.
    View in: PubMed
    Score: 0.025
  18. Lutfy K, Woodward RM, Keana JF, Weber E. Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists: MK-801 and ACEA-1011. Eur J Pharmacol. 1994 Feb 11; 252(3):261-6.
    View in: PubMed
    Score: 0.024
  19. Ren X, Lutfy K, Mangubat M, Ferrini MG, Lee ML, Liu Y, Friedman TC. Alterations in phosphorylated CREB expression in different brain regions following short- and long-term morphine exposure: relationship to food intake. J Obes. 2013; 2013:764742.
    View in: PubMed
    Score: 0.023
  20. Yoburn BC, Sierra V, Lutfy K. Chronic opioid antagonist treatment: assessment of receptor upregulation. Eur J Pharmacol. 1989 Nov 07; 170(3):193-200.
    View in: PubMed
    Score: 0.018
  21. Sierra V, Duttaroy A, Lutfy K, Candido J, Billings B, Zito SW, Yoburn BC. Potentiation of opioid analgesia by cocaine: the role of spinal and supraspinal receptors. Life Sci. 1992; 50(8):591-7.
    View in: PubMed
    Score: 0.005
  22. Yoburn BC, Lutfy K, Sierra V, Tortella FC. Tolerance develops to spinal morphine analgesia but not morphine-induced convulsions. Eur J Pharmacol. 1990 Jan 25; 176(1):63-7.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support